An intensive care unit nurse became the first person in New York state to receive the Pfizer/BioNTech Covid-19 vaccine on Monday, marking a pivotal turn in the US effort to control the deadly virus.
Sandra Lindsay, who has treated some of the sickest Covid-19 patients for months, was given the vaccine at Long Island Jewish Medical Center in the New York City borough of Queens, an early epicenter of the country’s Covid-19 outbreak, receiving applause on a livestream with New York Governor Andrew Cuomo.
“It didn’t feel any different from taking any other vaccine,” Lindsay said. “I feel hopeful today, relieved. I feel like healing is coming. I hope this marks the beginning of the end of a very painful time in our history.
I want to instill public confidence that the vaccine is safe.”
Minutes after Lindsay received the injection, US President Donald Trump sent a tweet: “First Vaccine Administered. Congratulations USA! Congratulations WORLD!”
Northwell Health, the largest health system in New York state, operates some of the select hospitals in the US that were administering the country’s first inoculations of the Pfizer/BioNTech Covid-19 vaccine outside trials on Monday.
The vaccine, developed by Pfizer and its German partner BioNTech, won emergency-use approval from federal regulators on Friday after it was found to be 95 per cent effective in preventing illness in a large clinical trial.
The first 2.9 million doses began to be shipped to distribution centers around the country on Sunday, just 11 months after the United States documented its first Covid-19 infections.
As of Monday, the US had registered more than 16 million cases and nearly 300,000 deaths from the virus.
Logistical challenge
The first US shipments of coronavirus vaccine departed from Pfizer’s facility in Kalamazoo, Michigan, on Sunday, packed into trucks with dry-ice to maintain the necessary sub-Arctic temperatures, and then were transported to UPS and FedEx planes waiting at air fields in Lansing and Grand Rapids, kicking off a national immunization endeavor of unprecedented complexity.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
More Stories
“Pajama Pawrty:” The Two Elements Of Fun In Mahira Khan’s Video
Sunil Grover drops clue about new project: Is he hinting at comeback on ‘The Kapil Sharma Show’?
Deepika Padukone, Shahid Kapoor join ‘Pawri Ho Rahi Hai’ trend- Check here